Delivery Order SPE2DR25D2205-SPE2DR26F1S87
Award Date 1/5/26
Potential Completion Date 1/6/26
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,742.35 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on January 5, 2026, with completion anticipated by January 6, 2026. This competitive award utilizing firm fixed pricing represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. The order, valued at $2,387.94 with a firm fixed price structure, will be fulfilled from the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by November 19, 2025. This is a non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $32,943.62 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was awarded competitively without a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,207.72 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $17,041.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic immunosuppressant medication primarily indicated for...
- The Defense Logistics Agency awarded a delivery order valued at $20,650.18 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for treating autoimmune conditions. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $16,574.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside contract was awarded on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,337.14 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, an injectable pharmaceutical used to treat autoimmune conditions. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 19, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $4,661.45 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate...